Prognostic value and immune landscape implications of using a novel homologous recombination repair pathway signature in prostate cancer: A retrospective cohort study.
- DOI
- 10.1177/03000605261487253
- Published
- 2026 Sep
- Container
- The Journal of international medical research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/03000605261487253,
title = {Prognostic value and immune landscape implications of using a novel homologous recombination repair pathway signature in prostate cancer: A retrospective cohort study.},
author = {Wang F and Tian YE and Liu Q and Sha MO and Wang P and Huang X and Tuoheti K and Chen J and Cui QI},
year = {2026},
journal = {The Journal of international medical research},
doi = {10.1177/03000605261487253},
url = {https://doi.org/10.1177/03000605261487253}
}RIS
TY - JOUR TI - Prognostic value and immune landscape implications of using a novel homologous recombination repair pathway signature in prostate cancer: A retrospective cohort study. AU - Wang F AU - Tian YE AU - Liu Q AU - Sha MO AU - Wang P AU - Huang X AU - Tuoheti K AU - Chen J AU - Cui QI PY - 2026 JO - The Journal of international medical research DO - 10.1177/03000605261487253 UR - https://doi.org/10.1177/03000605261487253 ER -
APA
F, W., YE, T., Q, L., MO, S., P, W., X, H., K, T., J, C., & QI, C. (2026). Prognostic value and immune landscape implications of using a novel homologous recombination repair pathway signature in prostate cancer: A retrospective cohort study.. The Journal of international medical research. https://doi.org/10.1177/03000605261487253
Source records
- pubmed · retrieved 2026-09-26T09:21:12.175Z